Creative Medical Technology Holdings, Inc.

CELZ Healthcare Biotechnology

Creative Medical Technology Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6,000.00, down 45.5% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 14.6% and free cash flow fell 27.1%, each against the same quarter a year earlier.

0.74 0.08 −9.76%
Market cap
$5.4M
P/E
0.0×
Fwd P/E
−1.3×
Dividend yield
—
F-score
4/9
Altman Z
−4.32
Beneish M
n/a
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

— 5 — —
ROE
(98.14%) (86.47%) (81.19%) (77.91%)
ROA
(93.58%) (82.81%) (77.93%) (73.30%)
ROIC
(1,758.41%) (1,213.03%) (1,304.33%) 0.00%
Return on Tangible Assets
(115.75%) (84.27%) (100.19%) (72.60%)
Average Days of Receivables
— 0.00 — —
Free Cash Flow per Share
(2.27) (2.46) (1.51) (1.59)
Free Cash Flow
(5.87) (5.86) (5.59) (5.90)
Other line items

Show all line items

Columns are period end dates